↓ Skip to main content

COMBINED ACAMPROSATE AND NALTREXONE, WITH COGNITIVE BEHAVIOURAL THERAPY IS SUPERIOR TO EITHER MEDICATION ALONE FOR ALCOHOL ABSTINENCE: A SINGLE CENTRES' EXPERIENCE WITH PHARMACOTHERAPY

Overview of attention for article published in Alcohol and Alcoholism, February 2006
Altmetric Badge

Mentioned by

policy
1 policy source
patent
1 patent
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
67 Dimensions

Readers on

mendeley
68 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
COMBINED ACAMPROSATE AND NALTREXONE, WITH COGNITIVE BEHAVIOURAL THERAPY IS SUPERIOR TO EITHER MEDICATION ALONE FOR ALCOHOL ABSTINENCE: A SINGLE CENTRES' EXPERIENCE WITH PHARMACOTHERAPY
Published in
Alcohol and Alcoholism, February 2006
DOI 10.1093/alcalc/agl007
Pubmed ID
Authors

Gerald F X Feeney, Jason P Connor, Ross McD Young, Jane Tucker, Annie McPherson

Abstract

To compare treatment outcomes amongst patients offered pharmacotherapy with either naltrexone or acamprosate used singly or in combination, in a 12-week outpatient cognitive behavioural therapy (CBT) programme for alcohol dependence.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 3%
Japan 1 1%
France 1 1%
Australia 1 1%
Unknown 63 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 18%
Student > Bachelor 10 15%
Student > Master 7 10%
Other 6 9%
Professor > Associate Professor 5 7%
Other 17 25%
Unknown 11 16%
Readers by discipline Count As %
Psychology 19 28%
Medicine and Dentistry 17 25%
Nursing and Health Professions 3 4%
Agricultural and Biological Sciences 3 4%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Other 9 13%
Unknown 14 21%